Oxford Biodynamics PLC
LSE:OBD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oxford Biodynamics PLC
LSE:OBD
|
UK |
|
Biorem Inc
XTSX:BRM
|
CA |
|
H
|
Hyundai Hyms Co Ltd
KOSDAQ:460930
|
KR |
|
Pluri Inc
NASDAQ:PLUR
|
IL |
|
Atlanta Braves Holdings Inc
F:E450
|
US |
|
H
|
Honghua Group Ltd
F:4HB
|
CN |
|
N
|
Neorigin Co Ltd
KOSDAQ:094860
|
KR |
|
PCI- PAL PLC
LSE:PCIP
|
UK |
|
A
|
Ansell Ltd
OTC:ANSLF
|
AU |
|
C
|
Cresud SACIF y A
F:CD8
|
AR |
|
T
|
Thumbage Co Ltd
KOSDAQ:208640
|
KR |
|
R
|
Ratch Group PCL
SET:RATCH
|
TH |
Intrinsic Value
Is OBD undervalued or overvalued?
See the intrinsic value estimate for Oxford Biodynamics PLC and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
OBD looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with OBD’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Oxford Biodynamics Does
Oxford Biodynamics is a biotechnology company that develops blood-based tests using its EpiSwitch platform, which looks at how DNA is folded in the cell to find disease signals. The company’s core work is to discover and validate biomarkers that can help identify cancer and other serious diseases earlier or more accurately than standard tests.
- Headquarters
- United Kingdom UK
- Employees
- 41
- IPO date
- Dec 6, 2016
Earnings Waterfall
Oxford Biodynamics PLC
The intrinsic value for Oxford Biodynamics PLC (OBD) under the Base Case is hidden GBX.
Compared with the current market price of 0.115 GBX, the stock appears hidden.